...
首页> 外文期刊>Journal of International Medical Research >Expression of c-erbB-2 and p53 in Breast Carcinoma Patients: Comparison with Traditional Prognostic Factors and Survival
【24h】

Expression of c-erbB-2 and p53 in Breast Carcinoma Patients: Comparison with Traditional Prognostic Factors and Survival

机译:乳腺癌患者中c-erbB-2和p53的表达:与传统预后因素和生存率的比较

获取原文
           

摘要

We aimed to determine the correlations between standard clinicopathological factors and expression of c-erbB-2 and p53 proteins, and to investigate the significance of these variables in relapse and disease-free survival (DFS) in breast carcinoma patients. Data from 200 patients who had undergone mastectomy for breast carcinoma were evaluated. Significant correlations were found between c-erbB-2 positivity and high histological grade (grade 3) tumour, p53 positivity and high grade tumour, and age < 60 years and oestrogen receptor negativity. Twenty-six patients (13%) developed a recurrence. Disease relapse was more frequent in patients who had axillary lymph node (ALN) metastasis, high grade tumour, c-erbB-2 positivity and p53 positivity; these variables were also associated with a shorter DFS. The effects of ALN metastasis and p53 positivity were significant. In conclusion, ALN metastasis and p53 positivity were important factors for predicting disease relapse in mastectomy-treated breast carcinoma patients; other clinicopathological criteria and c-erbB-2 positivity were not predictive.
机译:我们旨在确定标准临床病理因素与c-erbB-2和p53蛋白表达之间的相关性,并研究这些变量在乳腺癌患者复发和无病生存期(DFS)中的意义。评价了来自200例接受乳房切除术的乳腺癌患者的数据。发现c-erbB-2阳性与高组织学等级(3级)肿瘤,p53阳性和高等级肿瘤,年龄<60岁和雌激素受体阴性之间存在显着相关性。 26位患者(13%)复发。腋窝淋巴结转移,高级别肿瘤,c-erbB-2阳性和p53阳性的患者疾病复发更为频繁。这些变量还与较短的DFS相关。 ALN转移和p53阳性的影响是显着的。总之,ALN转移和p53阳性是预测乳房切除术治疗的乳腺癌患者疾病复发的重要因素。其他临床病理学标准和c-erbB-2阳性均不能预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号